Pan et al. [8] have developed a prognostic risk score for pediatric patients with non-malignancy-associated secondary HLH, defined by the following parameters measured at diagnosis: hemoglobin < 60 g/L, platelets < 30 × 109/L, and albumin < 25 g/L. Here, ALB is linked to hemophagocytic syndrome.